{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:53:23Z","timestamp":1791554003541,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rec.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:21:54Z","timestamp":1746444114000},"page":"1041-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study"],"prefix":"10.1016","volume":"78","author":[{"given":"Roberto","family":"Barriales-Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escobar-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vilanova Larena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Salazar-Mendiguch\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainara","family":"Echeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rebollo-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ram\u00f3n","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2025.04.004_bib0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2025.04.004_bib0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0210","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2025.04.004_bib0215","first-page":"47","article-title":"Hypertrophic Obstructive Cardiomyopathy","volume":"116","author":"Batzner","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"10.1016\/j.rec.2025.04.004_bib0220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical Course and Management of Hypertrophic Cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.04.004_bib0225","doi-asserted-by":"crossref","first-page":"11957","DOI":"10.1038\/s41598-017-12289-4","article-title":"Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.rec.2025.04.004_bib0230","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.04.004_bib0235","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.04.004_bib0240","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.04.004_bib0245","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.04.004_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2021.765876","article-title":"Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era","volume":"8","author":"Butzner","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.rec.2025.04.004_bib0255","first-page":"43","article-title":"Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany","author":"Schultze","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.04.004_bib0260","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.04.004_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/openhrt-2018-000963","article-title":"Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy","volume":"6","author":"Javidgonbadi","year":"2019","journal-title":"Open Heart."},{"key":"10.1016\/j.rec.2025.04.004_bib0270","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/13696998.2023.2208966","article-title":"Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States","volume":"26","author":"Naidu","year":"2023","journal-title":"J Med Econ."},{"key":"10.1016\/j.rec.2025.04.004_bib0275","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.semtcvs.2018.02.034","article-title":"Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy","volume":"30","author":"Solomon","year":"2018","journal-title":"Semin Thorac Cardiovasc Surg."},{"key":"10.1016\/j.rec.2025.04.004_bib0285","first-page":"404","article-title":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Indications, Technical Aspects, and Clinical Outcomes","volume":"29","author":"Spaziano","year":"2017","journal-title":"J Invasive Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amjms.2016.08.025","article-title":"Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach","volume":"352","author":"Aksu","year":"2016","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.rec.2025.04.004_bib0295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/13696998.2025.2468127","article-title":"Associations between procedural volume, costs, and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy in US hospitals","volume":"28","author":"Maksabedian Hernandez","year":"2025","journal-title":"J Med Econ."},{"key":"10.1016\/j.rec.2025.04.004_bib0300","series-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","first-page":"352","author":"Dolgin","year":"1994"},{"key":"10.1016\/j.rec.2025.04.004_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2019.09.1764","article-title":"PMU146 validation and representativeness of the Spanish BIG-PAC database: integrated computerized medical records for research into epidemiology, medicines and health resource use (real word evidence)","author":"Sicras-Mainar","year":"2019","journal-title":"Value in Health;"},{"key":"10.1016\/j.rec.2025.04.004_bib0310","article-title":"State official gazette","year":"2022","journal-title":"Official gazettes of the autonomous communities"},{"key":"10.1016\/j.rec.2025.04.004_bib0315","unstructured":"Instituto Nacional de Estad\u00edstica. \u00cdndices nacionales: general y de grupos ECOICOP (22553). Available at: https:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=22553. Accessed 27 Jun 2024."},{"key":"10.1016\/j.rec.2025.04.004_bib0320","unstructured":"Instituto Nacional de Estad\u00edstica. \u00bfCu\u00e1nto ha variado el IPC desde..? 2024. Available at: https:\/\/www.ine.es\/varipc\/verVariaciones.do?idmesini=1&anyoini=2023&idmesfin=1&anyofin=2022&ntipo=1&enviar=Calcular. Accessed 27 Jun 2024."},{"key":"10.1016\/j.rec.2025.04.004_bib0325","unstructured":"Base de datos de costes sanitarios espa\u00f1oles: eSalud [Internet] [Internet]. 2007 [cited 5 February 2024]. Available at: http:\/\/www.oblikue.com\/bddcostes\/. Accessed 27 Jun 2024."},{"key":"10.1016\/j.rec.2025.04.004_bib0330","unstructured":"Servicio Canario de la Salud. Resoluci\u00f3n de 29 de marzo de 2017. Bolet\u00edn Oficial de Canarias, n\u00fam. 67, 5 de abril de 2017. 2017."},{"key":"10.1016\/j.rec.2025.04.004_bib0335","unstructured":"Departament de salut. Orden SLT\/63\/2020, de 8 de marzo. Diari Oficial de la Generalitat de Catalunya, n\u00famero 8134 del 15 de mayo del 2020. 2020."},{"key":"10.1016\/j.rec.2025.04.004_bib0340","unstructured":"Ministerio de Sanidad Consumo y Bienestar Social (2023). Registro de altas. Grupos Relacionados por el Diagn\u00f3stico (GRD-APR) \u2013 CMBD 2021."},{"key":"10.1016\/j.rec.2025.04.004_bib0345","unstructured":"Instituto Nacional de Estad\u00edstica. Ganancia media laboral por edad y sexo. Available at: https:\/\/www.ine.es\/dynt3\/inebase\/index.htm?padre=4563&capsel=4563. Accessed 8 Apr 2021."},{"key":"10.1016\/j.rec.2025.04.004_bib0350","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jtcvs.2021.04.001","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"162","author":"Ommen","year":"2021","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10.1016\/j.rec.2025.04.004_bib0355","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","article-title":"Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy","volume":"81","author":"Maron","year":"2023","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0360","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.3390\/jcm12072725","article-title":"Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy","volume":"12","author":"Maurizi","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2025.04.004_bib0365","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jjcc.2021.11.023","article-title":"Percutaneous transluminal septal myocardial ablation: past, present, and future","volume":"80","author":"Maekawa","year":"2022","journal-title":"J Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0375","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/13696998.2021.1978242","article-title":"Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States","volume":"24","author":"Jain","year":"2021","journal-title":"J Med Econ."},{"key":"10.1016\/j.rec.2025.04.004_bib0380","first-page":"100089","article-title":"Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population","volume":"13","author":"Butzner","year":"2022","journal-title":"Am Heart J Plus."},{"key":"10.1016\/j.rec.2025.04.004_bib0385","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/CLEP.S139300","article-title":"Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes","volume":"9","author":"Magnusson","year":"2017","journal-title":"Clin Epidemiol."},{"key":"10.1016\/j.rec.2025.04.004_bib0390","unstructured":"Gobierno de Espa\u00f1a. Ley Org\u00e1nica 3\/2018, de 5 de diciembre, de Protecci\u00f3n de Datos Personales y garant\u00eda de los derechos digitales. In: Jefatura del Estado, editor. 2018. p. 119788-857. Available at: https:\/\/www.boe.es\/eli\/es\/lo\/2018\/12\/05\/3. Accessed 30 May 2024."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:32:46Z","timestamp":1791552766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585725001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1885585725001380"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2025.04.004","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2025.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}